Synthetic cannabinoids sent 30 people to the ICU with life-threatening complications | Research

The takeaway

A case series of 30 ICU patients found synthetic cannabinoid ingestion caused coma, seizures, acute respiratory failure, and one death, with standard drug tests unable to detect the substances.

Emergency physicians, toxicologists, ICU clinicians, and public health officials.

70% required intubation; standard drug tests negative in 53%

What the researchers found

Over two years, 30 patients were admitted to the ICU after synthetic cannabinoid use. Presenting diagnoses included coma (33%), agitation (33%), and seizures (20%). Seventy percent required intubation, 60% had acute respiratory failure, and 26% developed rhabdomyolysis. One patient died of ARDS. Standard toxicology screens were negative in 53% of cases.

Why it matters

Synthetic cannabinoids (K2, Spice) are far more dangerous than natural cannabis and are undetectable by standard drug tests. This series documents the severity of complications that can result, including death.

The numbers in context

30 ICU patients; mean age 41; 80% male; 33% presented in coma; 70% required intubation; 60% had respiratory failure; 26% had rhabdomyolysis; 1 death; 53% had negative standard toxicology.

How the study worked

Retrospective case series of 30 adults admitted to ICU from 2014-2016 with confirmed or suspected synthetic cannabinoid ingestion, published in JAMA Network Open.

What this study cannot tell us

Single-institution case series; no control group; retrospective data; many patients had polysubstance use histories; 53% left against medical advice, limiting follow-up.

How to read the evidence

Moderate: published in JAMA Network Open with detailed clinical data, though limited by retrospective single-institution design.

When this study was published

Published 2020.

The bigger picture

The inability of standard drug tests to detect synthetic cannabinoids, combined with their severe toxicity profile, makes them a particularly dangerous public health threat. These products bear little pharmacological resemblance to natural cannabis despite being marketed as alternatives.

Questions still open

How can emergency departments better identify synthetic cannabinoid intoxication when standard tests fail? What specific compounds were involved in the most severe cases?

Common questions

Can standard drug tests detect synthetic cannabinoids?

No. In this series, routine toxicology screening was negative in 53% of confirmed synthetic cannabinoid cases. Specialized testing is needed.

How dangerous are synthetic cannabinoids compared to natural cannabis?

Far more dangerous. This series documented coma, seizures, respiratory failure requiring intubation, and one death. Natural cannabis does not typically produce these life-threatening complications.

Read the original research

Critical Illness Secondary to Synthetic Cannabinoid Ingestion.

JAMA network open, 3(7), e208516

View on PubMed ↗Publisher’s paper ↗

Citation

Kourouni, Ismini; Mourad, Bashar; Khouli, Hassan; Shapiro, Janet M; Mathew, Joseph P. (2020). Critical Illness Secondary to Synthetic Cannabinoid Ingestion.. JAMA network open, 3(7), e208516. https://doi.org/10.1001/jamanetworkopen.2020.8516